Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibodies, Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT06327997
What this trial is testing

An Exploratory Study by Fast CAR T Cells

Who this might be right for
Solid Tumor
Shanghai Cell Therapy Group Co.,Ltd 20
Early research (Phase 1)Study completedNCT02463227
What this trial is testing

Evaluating the Safety, Pharmacokinetics, and Antiviral Activity of a Human Monoclonal Antibody (VRC01) in HIV-Infected Adults Undergoing a Brief Treatment Interruption

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 14
Not applicableStudy completedNCT04609085
What this trial is testing

SARS-COV2 Pandemic Serosurvey in a Rare Disease Population

Who this might be right for
SARS-COV2 Virus
National Institute of Allergy and Infectious Diseases (NIAID) 730
Early research (Phase 1)Study completedNCT00002268
What this trial is testing

A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Sandoz
Not applicableStudy completedNCT07387211
What this trial is testing

Study SARS-CoV-2-CZ-PREVAL-II - Arm of the Olomouc Region

Who this might be right for
SARS-CoV-2SARS-CoV-2 (COVID-19) Infection
The Institute of Molecular and Translational Medicine, Czech Republic 2,484
Large-scale testing (Phase 3)UnknownNCT05017792
What this trial is testing

Evaluation of Clinical and Antibody Response to Covid-19 Vaccination Strategy in TBRI, Egypt

Who this might be right for
Covid19
Samia Hassan El-Shishtawy 200
Not applicableUnknownNCT05075928
What this trial is testing

Description of a Cohort of Covid-19 Patients With a Circulating Anticoagulant

Who this might be right for
SARS-COV-2
University Hospital, Strasbourg, France 100
Large-scale testing (Phase 3)Ended earlyNCT04644185
What this trial is testing

The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19

Who this might be right for
Covid19
Sinocelltech Ltd. 102
Early research (Phase 1)Study completedNCT04273217
What this trial is testing

Determine the Safety of AV-1, an Antibody Being Developed for Treatment of Dengue, in Healthy Volunteers

Who this might be right for
Healthy Volunteers
AbViro LLC 42
Not applicableStudy completedNCT04844489
What this trial is testing

Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People

Who this might be right for
Autoimmune or Autoinflammatory DiseasesHIVMultiple Sclerosis+2 more
Assistance Publique - Hôpitaux de Paris 377
Large-scale testing (Phase 3)Study completedNCT01983540
What this trial is testing

Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination

Who this might be right for
DiphtheriaTetanusWhooping Cough+3 more
Sanofi Pasteur, a Sanofi Company 558
Not applicableStudy completedNCT01048372
What this trial is testing

Observational Study of Blood Treated With Cytolin

Who this might be right for
HIV Infections
CytoDyn, Inc. 20
Testing effectiveness (Phase 2)Ended earlyNCT04539483
What this trial is testing

Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 1 Infection

Who this might be right for
Herpes Labialis
Heidelberg ImmunoTherapeutics GmbH 761
Not applicableActive Not RecruitingNCT06197802
What this trial is testing

Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 392
Not applicableUnknownNCT06457477
What this trial is testing

Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB Patients

Who this might be right for
Chronic Hepatitis B
Beijing 302 Hospital 50
Testing effectiveness (Phase 2)Study completedNCT03707977
What this trial is testing

Dual bNAb Treatment in Children

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)Looking for participantsNCT04319367
What this trial is testing

A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).

Who this might be right for
HIV/AIDS and Infections
Imperial College London 72
Early research (Phase 1)Study completedNCT03928821
What this trial is testing

Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Combinations of Monoclonal Antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS Administered Via Intravenous Infusion in Healthy, HIV-uninfected Adult Participants

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 27
Not applicableStudy completedNCT04473365
What this trial is testing

Rapid Diagnostic Profiling of SARS-CoV-2 (COVID-19)

Who this might be right for
SARS-CoV-2COVID-19
Mekelle University 838
Early research (Phase 1)Study completedNCT06851611
What this trial is testing

The Safety and Antibody Response of the Nasal COV2 Vaccine Against the SARS-CoV-2 Virus

Who this might be right for
COVID19, Sars-Cov-2
Rokote Laboratories Finland Oy 40
Next Page